The ACMs were transferred to 96-well plates, and each ACM was placed in an individual well. MSCs were trypsinized, centrifuged, resuspended and injected into the ACMs at multiple sites using a 22-gauge needle at a concentration of 30 × 106/mL to ensure that a sufficient number of cells were injected into the ACMs to construct the engineered corpus cavernosum. The seeded ACMs were then preserved in a 37 °C incubator for 6 hours to allow the cells to aggregate and attach to the ACMs. Next, the seeded ACMs were transferred to 12-well plates containing 3 mL DMEM/F12 supplemented with 10% FBS and 1% penicillin-streptomycin, which were changed daily. The 12-well plates were placed on a shaker spinning at 40 RPM for 14 days in a 37 °C incubator. The seeded ACM samples were examined by haematoxylin-eosin staining using paraffin-embedded sections every 2 days to observe the state of the seeded cells.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.